If she is getting "clued in" by KOLs on what appears to be working, and what appears not to be working in clinical trials, I'll take her word for it any day over what statistics might say, or what previous data might have said.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.